The MMR vaccine in the United Kingdom is a combined vaccine which immunizes against measles, mumps and rubella. In 2023/24, 85.6 percent of children in Scotland had received the second dose of the vaccine by their fifth birthday, compared to 83.9 percent of children in England. Rise of measles in recent years In 2018, there were 989 cases of measles in England and Wales, this was the highest number of annual recorded cases since 2013. From 2000 to 2019, cases of measles generally increased in England and Wales. Views towards vaccines in the UK In the UK most of the population believe in the safety and effectiveness of vaccines. A 2018 survey of British respondents showed that 89 percent of the population believed that vaccines are important for children to have. In the same survey question, sixteen other European countries had a higher belief in the importance of child vaccinations than the UK, compared to twenty-one other countries which scored lower than the UK.

This study provides a macro-level societal and health system focused analysis of child vaccination rates in 30 European countries, exploring the effect of context on coverage. The importance of demography and health system attributes on health care delivery are recognized in other fields, but generally overlooked in vaccination. The analysis is based on correlating systematic data built up by the Models of Child Health Appraised (MOCHA) Project with data from international sources, so as to exploit a one-off opportunity to set the analysis within an overall integrated study of primary care services for children, and the learning opportunities of the ‘natural European laboratory’. The descriptive analysis shows an overall persistent variation of coverage across vaccines with no specific vaccination having a low rate in all the EU and EEA countries. However, contrasting with this, variation between total uptake per vaccine across Europe suggests that the challenge of low rates is related to country contexts of either policy, delivery, or public perceptions. Econometric analysis aiming to explore whether some population, policy and/or health system characteristics may influence vaccination uptake provides important results - GDP per capita and the level of the population’s higher education engagement are positively linked with higher vaccination coverage, whereas mandatory vaccination policy is related to lower uptake rates. The health system characteristics that have a significant positive effect are a cohesive management structure; a high nurse/doctor ratio; and use of practical care delivery reinforcements such as the home-based record and the presence of child components of e‑health strategies.

The average for 2022 based on 187 countries was 84 percent. The highest value was in Antigua and Barbuda: 99 percent and the lowest value was in North Korea: 0 percent. The indicator is available from 1980 to 2022. Below is a chart for all countries where data are available.

In 2022, the share of children aged one year old who were immunized against tuberculosis was high in the Asia Pacific region. Many countries had near perfect immunization rates, with 99 percent of one-year-old children immunized against tuberculosis. In comparison, TB immunization rate of children was 63 and zero percent in the Philippines and North Korea, respectively.

Childhood Vaccination Coverage Statistics- England 2017-18 [NS] The information in this bulletin about immunisation statistics in England comes from Public Health England (PHE). Information on childhood vaccination coverage at ages 1, 2 and 5 years is collected through the Cover of Vaccination Evaluated Rapidly (COVER) data collection for Upper Tier Local Authorities (LAs). Information on children aged 2 and 3 vaccinated against seasonal flu are collected from GPs through PHE's ImmForm system.

BackgroundImmunizations are one of the most effective tools a community can use to increase overall health and decrease the burden of vaccine-preventable diseases. Nevertheless, socioeconomic status, geographical location, education, and a child's sex have been identified as contributing to inequities in vaccine uptake in low- and middle-income countries (LMICs). Madagascar follows the World Health Organization's Extended Programme on Immunization (EPI) schedule, yet vaccine distribution remains highly inequitable throughout the country. This systematic review sought to understand the differences in EPI vaccine uptake between boys and girls in Madagascar.MethodsA systematic literature search was conducted in August 2021 through MEDLINE, the Cochrane Library, Global Index Medicus, and Google Scholar to identify articles reporting sex-disaggregated vaccination rates in Malagasy children. Gray literature was also searched for relevant data. All peer-reviewed articles reporting sex-disaggregated data on childhood immunizations in Madagascar were eligible for inclusion. Risk of bias was assessed using a tool designed for use in systematic reviews. Data extraction was conducted with a pre-defined data extraction tool. Sex-disaggregated data were synthesized to understand the impact of a child's sex on vaccination status.FindingsThe systematic search identified 585 articles of which a total of three studies were included in the final data synthesis. One additional publication was included from the gray literature search. Data from included articles were heterogeneous and, overall, indicated similar vaccination rates in boys and girls. Three of the four articles reported slightly higher vaccination rates in girls than in boys. A meta-analysis was not conducted due to the heterogeneity of included data. Six additional barriers to immunization were identified: socioeconomic status, mother's education, geographic location, supply chain issues, father's education, number of children in the household, and media access.InterpretationThe systematic review revealed the scarcity of available sex-stratified immunization data for Malagasy children. The evidence available was limited and heterogeneous, preventing researchers from conclusively confirming or denying differences in vaccine uptake based on sex. The low vaccination rates and additional barriers identified here indicate a need for increased focus on addressing the specific obstacles to vaccination in Madagascar. A more comprehensive assessment of sex-disaggregated vaccination status of Malagasy children and its relationship with such additional obstacles is recommended. Further investigation of potential differences in vaccination status will allow for the effective implementation of strategies to expand vaccine coverage in Madagascar equitably.Funding and registrationAH, BT, FM, GN, and RR are supported by a grant from the Bill and Melinda Gates Foundation (grant number: OPP1205877). The review protocol is registered in the Prospective Register of Systematic Reviews (PROSPERO ID: CRD42021265000).

BackgroundThe COVID-19 pandemic has disrupted routine childhood vaccinations worldwide with low- and middle-income countries (LMICs) most affected. This study aims to quantify levels of disruption to routine vaccinations in LMICs.MethodsA systematic review (PROSPERO CRD42021286386) was conducted of MEDLINE, Embase, Global Health, CINAHL, Scopus and MedRxiv, on the 11th of February 2022. Primary research studies published from January 2020 onwards were included if they reported levels of routine pediatrics vaccinations before and after March 2020. Study appraisal was performed using NHLBI tool for cross-sectional studies. Levels of disruption were summarized using medians and interquartile ranges.ResultsA total of 39 cross-sectional studies were identified. These showed an overall relative median decline of −10.8% [interquartile range (IQR) −27.6%, −1.4%] across all vaccines. Upper-middle-income countries (upper-MICs) (−14.3%; IQR −24.3%, −2.4%) and lower-MICs (−18.0%; IQR −48.6%, −4.1%) showed greater declines than low-income countries (−3.1%; IQR −12.8%, 2.9%), as did vaccines administered at birth (−11.8%; IQR −27.7%, −3.5%) compared to those given after birth (−8.0%; IQR −28.6%, −0.4%). Declines during the first 3 months of the pandemic (−8.1%; IQR −35.1%, −1.4%) were greater than during the remainder of 2020 (−3.9%; IQR −13.0%, 11.4%) compared to baseline.ConclusionThere has been a decline in routine pediatric vaccination, greatest in MICs and for vaccines administered at birth. Nations must prioritize catch-up programs alongside public health messaging to encourage vaccine uptake.Systematic review registrationIdentifier: CRD42021286386.

France FR: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 90.000 % in 2017. This stayed constant from the previous number of 90.000 % for 2016. France FR: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 84.000 % from Dec 1983 (Median) to 2017, with 35 observations. The data reached an all-time high of 91.000 % in 2015 and a record low of 15.000 % in 1983. France FR: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s France – Table FR.World Bank.WDI: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Denmark DK: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 94.000 % in 2016. This records an increase from the previous number of 91.000 % for 2015. Denmark DK: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 88.500 % from Dec 1987 (Median) to 2016, with 30 observations. The data reached an all-time high of 99.000 % in 2000 and a record low of 72.000 % in 1988. Denmark DK: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Denmark – Table DK.World Bank: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Spain ES: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 97.000 % in 2016. This records an increase from the previous number of 96.000 % for 2015. Spain ES: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 95.000 % from Dec 1981 (Median) to 2016, with 36 observations. The data reached an all-time high of 99.000 % in 1990 and a record low of 8.000 % in 1981. Spain ES: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Spain – Table ES.World Bank: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

The average for 2022 based on 187 countries was 85 percent. The highest value was in Antigua and Barbuda: 99 percent and the lowest value was in North Korea: 0 percent. The indicator is available from 1980 to 2022. Below is a chart for all countries where data are available.

Nicaragua, Antigua and Barbuda, and Cuba were the Latin American countries with the highest coverage of the second and last dose of the measles, mumps, and rubella (MMR2) vaccine in 2022. That year, the MMR vaccination coverage reached 100 percent of the population in these nations. The MMR vaccine is usually given to children, but it can also be granted to adults who do not have evidence of immunity.

In 2022, many Southeast Asian countries had near perfect immunization rates for tuberculosis, with 99 percent of one-year-old children immunized in Brunei and Thailand, respectively. In comparison, the TB immunization rate of children was 63 percent in the Philippines.

This statistic displays the percentage of the world population that has been vaccinated with select routine vaccinations as of 2022. According to the data, globally, just 51 percent of people have had a last Rota vaccine against the Rotavirus. Rotavirus is responsible for an inflammation of the intestines and stomach and causes severe gastrointestinal and diarrheal disease.

Vaccination success worldwide

All around the world, vaccinations have been effective in reducing the number of cases and deaths of various communicable diseases since the introduction of global vaccination programs in the 1970’s. For example, between 2000 and 2021, millions of deaths due to measles have been averted all over the globe. The final aim of vaccination is to eradicate the disease entirely, as is the case with smallpox: no cases have been reported since 1978.

Under-immunized groups

Despite the success of immunization programs, there are still groups lacking the recommended vaccinations; this is often due to a lack of access or resources within a country or region, although under-immunization can also be a result of hesitancy due to personal beliefs. Individual rights involving compulsory vaccinations has also remained a hot topic over the years- for example, support for government-required childhood vaccinations has decreased in the U.S. since 1991. In order to further grow vaccination coverage, targeted strategies are needed for under-immunized and vaccine-hesitant groups using context-specific interventions to increase and monitor immunization rates.

The global pediatric vaccines market size reached USD 39.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 72.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.89% during 2025-2033. The growing conduction of vaccination programs, increasing focus on combination vaccines, and rising partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are some of the major factors propelling the market.

IMARC Group provides an analysis of the key trends in each segment of the global pediatric vaccines market report, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on type, technology, and application.

Global Child Immunization Coverage Against Pol3 by Country, 2023 Discover more data with ReportLinker!

Canada CA: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 92.000 % in 2022. This records an increase from the previous number of 90.000 % for 2021. Canada CA: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 92.000 % from Dec 1987 (Median) to 2022, with 36 observations. The data reached an all-time high of 97.000 % in 1996 and a record low of 70.000 % in 1987. Canada CA: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Canada – Table CA.World Bank.WDI: Social: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.;WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).;Weighted average;

San Marino Immunization: Measles: % of Children Aged 12-23 Months data was reported at 82.000 % in 2017. This stayed constant from the previous number of 82.000 % for 2016. San Marino Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 94.000 % from Dec 1991 (Median) to 2017, with 27 observations. The data reached an all-time high of 99.000 % in 2000 and a record low of 81.000 % in 2014. San Marino Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s San Marino – Table SM.World Bank: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Netherlands NL: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 94.000 % in 2016. This records a decrease from the previous number of 95.000 % for 2015. Netherlands NL: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 95.000 % from Dec 1980 (Median) to 2016, with 37 observations. The data reached an all-time high of 96.000 % in 2014 and a record low of 91.000 % in 1981. Netherlands NL: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Netherlands – Table NL.World Bank: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Global Measles Immunization Coverage for Children by Country, 2023 Discover more data with ReportLinker!